Unibest

Pharmaceutical intermediates

Empagliflozin Intermediates

8 pharmaceutical intermediates for Empagliflozin. Indication: Chronic Renal Insufficiency; Heart Failure; Type 2 Diabetes Mellitus.

提交项目All intermediates

About Empagliflozin

Originator
Boehringer Ingelheim International Gmbh
Indication
Chronic Renal Insufficiency; Heart Failure; Type 2 Diabetes Mellitus
Approved Date
12/09/2016
DS/DP
08/01/2028

Available intermediates

8 intermediates currently listed for Empagliflozin. Request specifications, documentation or a quotation for any item below.

Empagliflozin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(5-Bromo-2-chlorophenyl)(4-fluorophenyl)methanone915095-85-1//
(5-Bromo-2-chlorophenyl)[4-[[(3S)-tetrahydro-3-furanylloxy]phenyllmethanone915095-84-0//
(S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran915095-94-2//
(S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran915095-89-5//
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl] -D-glucitol tetraacetate915095-99-7//
(S)-(+)-3-Hydroxytetrahydrofuran86087-23-2//
4-((5-Bromo-2-chlorophenyl)methyl)phenol864070-18-8//
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone32384-65-9//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Empagliflozin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →